Default: JAAD Case Reports

ISSN:

Journal Home

Journal Guideline

JAAD Case Reports Q3 Unclaimed

Elsevier Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

JAAD Case Reports is a journal indexed in SJR in Dermatology with an H index of 31. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 540 €. The scope of the journal is focused on dermatology. It has an SJR impact factor of 0,397 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,397.

JAAD Case Reports focuses its scope in these topics and keywords: case, eruption, patient, treatment, immunosuppression, heart, increase, intensive, dupilumabinduced, itraconazolelifitegrast, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

DOAJ WOS
Categories: Dermatology (Q3)
Price

540 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

JAAD Case Reports

0,397

SJR Impact factor

31

H Index

448

Total Docs (Last Year)

1400

Total Docs (3 years)

3934

Total Refs

1513

Total Cites (3 years)

1347

Citable Docs (3 years)

1.06

Cites/Doc (2 years)

8.78

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


case, eruption, patient, treatment, immunosuppression, heart, increase, intensive, dupilumabinduced, itraconazolelifitegrast, incidence, kidney, leprosy, literaturetreatment, locus, minocycline, minoris, myopericarditis, nephrotic, healed, florida, fixed, alitretinoin, burn, care, central, craquelé, dermatosis, diosd, drug, dupilumab, effect, erythroderma, facial, febrile, dermatology

FAQS